TATACHEMNSEQ2FY24November 10, 2023

Tata Chemicals Limited

3,197words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
ied. Important factors that could make a difference to the Company’s operations include, among others, economic conditions affecting demand / supply, price conditions in the domestic and overseas markets
₹ 3,998
tember 2023 3 Performance Highlights - Consolidated Q2FY24 (₹ Crore) H1FY24 (₹ Crore) Revenue ₹ 3,998 Cr (CY) vs. ₹ 4,239 Cr (PY) Revenue ₹ 8,216 Cr (CY) vs ₹ 8,234 Cr (PY) EBITDA ₹ 819 Cr (CY) vs.
₹ 4,239
ormance Highlights - Consolidated Q2FY24 (₹ Crore) H1FY24 (₹ Crore) Revenue ₹ 3,998 Cr (CY) vs. ₹ 4,239 Cr (PY) Revenue ₹ 8,216 Cr (CY) vs ₹ 8,234 Cr (PY) EBITDA ₹ 819 Cr (CY) vs. ₹ 920 Cr (PY) EBITD
₹ 8,216
lidated Q2FY24 (₹ Crore) H1FY24 (₹ Crore) Revenue ₹ 3,998 Cr (CY) vs. ₹ 4,239 Cr (PY) Revenue ₹ 8,216 Cr (CY) vs ₹ 8,234 Cr (PY) EBITDA ₹ 819 Cr (CY) vs. ₹ 920 Cr (PY) EBITDA ₹ 1,862 Cr (CY) vs. ₹ 1
₹ 8,234
Crore) H1FY24 (₹ Crore) Revenue ₹ 3,998 Cr (CY) vs. ₹ 4,239 Cr (PY) Revenue ₹ 8,216 Cr (CY) vs ₹ 8,234 Cr (PY) EBITDA ₹ 819 Cr (CY) vs. ₹ 920 Cr (PY) EBITDA ₹ 1,862 Cr (CY) vs. ₹ 1,935 Cr (PY) PAT
₹ 819
Revenue ₹ 3,998 Cr (CY) vs. ₹ 4,239 Cr (PY) Revenue ₹ 8,216 Cr (CY) vs ₹ 8,234 Cr (PY) EBITDA ₹ 819 Cr (CY) vs. ₹ 920 Cr (PY) EBITDA ₹ 1,862 Cr (CY) vs. ₹ 1,935 Cr (PY) PAT ₹ 495 Cr (CY) vs. ₹ 685
₹ 920
Cr (CY) vs. ₹ 4,239 Cr (PY) Revenue ₹ 8,216 Cr (CY) vs ₹ 8,234 Cr (PY) EBITDA ₹ 819 Cr (CY) vs. ₹ 920 Cr (PY) EBITDA ₹ 1,862 Cr (CY) vs. ₹ 1,935 Cr (PY) PAT ₹ 495 Cr (CY) vs. ₹ 685 Cr (PY) PAT ₹ 1
₹ 1,862
(PY) Revenue ₹ 8,216 Cr (CY) vs ₹ 8,234 Cr (PY) EBITDA ₹ 819 Cr (CY) vs. ₹ 920 Cr (PY) EBITDA ₹ 1,862 Cr (CY) vs. ₹ 1,935 Cr (PY) PAT ₹ 495 Cr (CY) vs. ₹ 685 Cr (PY) PAT ₹ 1,073 Cr (CY) vs ₹ 1,326 C
₹ 1,935
16 Cr (CY) vs ₹ 8,234 Cr (PY) EBITDA ₹ 819 Cr (CY) vs. ₹ 920 Cr (PY) EBITDA ₹ 1,862 Cr (CY) vs. ₹ 1,935 Cr (PY) PAT ₹ 495 Cr (CY) vs. ₹ 685 Cr (PY) PAT ₹ 1,073 Cr (CY) vs ₹ 1,326 Cr (PY) FCF ₹ 426 C
₹ 495
Cr (PY) EBITDA ₹ 819 Cr (CY) vs. ₹ 920 Cr (PY) EBITDA ₹ 1,862 Cr (CY) vs. ₹ 1,935 Cr (PY) PAT ₹ 495 Cr (CY) vs. ₹ 685 Cr (PY) PAT ₹ 1,073 Cr (CY) vs ₹ 1,326 Cr (PY) FCF ₹ 426 Cr (CY) vs. ₹ 383 Cr
₹ 685
819 Cr (CY) vs. ₹ 920 Cr (PY) EBITDA ₹ 1,862 Cr (CY) vs. ₹ 1,935 Cr (PY) PAT ₹ 495 Cr (CY) vs. ₹ 685 Cr (PY) PAT ₹ 1,073 Cr (CY) vs ₹ 1,326 Cr (PY) FCF ₹ 426 Cr (CY) vs. ₹ 383 Cr (PY) Gross Debt
₹ 1,073
20 Cr (PY) EBITDA ₹ 1,862 Cr (CY) vs. ₹ 1,935 Cr (PY) PAT ₹ 495 Cr (CY) vs. ₹ 685 Cr (PY) PAT ₹ 1,073 Cr (CY) vs ₹ 1,326 Cr (PY) FCF ₹ 426 Cr (CY) vs. ₹ 383 Cr (PY) Gross Debt Net Debt ₹6,048 Cr (
← All transcriptsTATACHEM stock page →